+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Companion Diagnostics Market 2020-2026

  • ID: 5129874
  • Report
  • June 2020
  • Region: Global
  • Orion Market Research Private Limited

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc.
  • bioMérieux SA
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • QIAGEN NV
  • MORE
Global Companion Diagnostics Market Size, Share & Trends Analysis Report by Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), and Others) and by Indication (Breast Cancer, Lung Cancer, Melanoma, Neurological Diseases, and Others) and Forecast 2020-2026
The global companion diagnostics market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the growing awareness of targeted therapy and precision medicine, increasing focus on next-generation sequencing technologies, and growing application of companion diagnostics. The companion diagnostics market is classified on the basis of technology and indication. Based on technology, the market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next-generation sequencing (NGS), and others. Based on indication, the market is segregated into breast cancer, lung cancer, melanoma, neurological diseases, and others. Among these indications, the companion diagnostics finds a significant application in lung cancer, owing to the presence of some of companion diagnostics tests that are made mandatory for the test of targeted therapies for lung cancer.

Geographically, the global companion diagnostics market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The US with a highly matured and technologically advanced healthcare infrastructure, contributes considerably in the companion diagnostics market. The presence of huge regulatory bodies such as FDA, further contributes in the increase in the development and test of drugs through such testing tools, which in turn, offers growth to the companion diagnostics market in North America. In addition, Asia-Pacific is expected to project a considerable growth during the forecast period. This growth is backed by the rise in proteomics and genomics research and increasing development of personalized medicine in the region, especially in India, China, South Korea, and Japan.

The global companion diagnostics market is influenced by product development and advancements conducted by the market players. The key players of the companion diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., bioMérieux SA, Thermo Fisher Scientific Inc., Promega Corp., QIAGEN NV, Myriad Genetics, Inc., AstraZeneca PLC, and Merck Co. & Inc. These players are playing a significant role in the growth of the companion diagnostics market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global companion diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Companion Diagnostics Market Research and Analysis by Technology
2. Global Companion Diagnostics Market Research and Analysis by Indication

The Report covers:
  • Comprehensive research methodology of the global companion diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global companion diagnostics market.
  • Insights about market determinants which are stimulating the global market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc.
  • bioMérieux SA
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • QIAGEN NV
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Abbott Laboratories
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. F. Hoffmann-La Roche Ltd.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. bioMérieux SA
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Myriad Genetics, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. QIAGEN NV
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Companion Diagnostics Market by Technology
5.1.1. Polymerase Chain Reaction (PCR)
5.1.2. In Situ Hybridization (ISH)
5.1.3. Immunohistochemistry (IHC)
5.1.4. Next-Generation Sequencing (NGS)
5.1.5. Others (Gene Sequencing)
5.2. Global Companion Diagnostics Market by Indication
5.2.1. Breast Cancer
5.2.2. Lung Cancer
5.2.3. Melanoma
5.2.4. Neurological Diseases
5.2.5. Others (Gastric Cancer)

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Laboratories
7.2. Abnova Corp.
7.3. Agilent Technologies, Inc.
7.4. Almac Group
7.5. Amgen Inc.
7.6. AstraZeneca PLC
7.7. Biocartis NV
7.8. bioMérieux SA
7.9. F. Hoffmann-La Roche Ltd.
7.10. Guardant Health, Inc.
7.11. Illumina, Inc.
7.12. Leica Biosystems
7.13. Merck & Co., Inc.
7.14. Myriad Genetics, Inc.
7.15. Promega Corp.
7.16. Protagen AG
7.17. QIAGEN NV
7.18. Siemens AG
7.19. Sysmex Corp.
7.20. Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Abnova Corp.
  • Agilent Technologies, Inc.
  • Almac Group
  • Amgen Inc.
  • AstraZeneca PLC
  • Biocartis NV
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Leica Biosystems
  • Merck & Co., Inc.
  • Myriad Genetics, Inc.
  • Promega Corp.
  • Protagen AG
  • QIAGEN NV
  • Siemens AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll